|IDT Australia Limited|
45 Wadhurst Drive
Australia - Map
Phone: 61 3 9801 8888
Fax: 61 3 9801 8773
IDT Australia Limited, a pharmaceutical contract manufacturing company, provides products, research and development, and other technical services for the pharmaceutical and allied industries primarily in Australia. It is involved in the development, scale-up, and production of high potency active pharmaceutical ingredients, cytotoxic active pharmaceutical ingredients, hormones, and toxic reagents. The companys product portfolio comprises anti-cancer drugs, anti-psychotics, antibiotics, narcotics, and anti-inflammatory drugs. It also offers a range of specialist formulation development manufacturing, packaging, and dispensing services for new products and clinical trial supplies; manufactures active and placebo clinical trial supplies in various dosage forms, such as tablets, capsules, suspensions, liquids, and ointments; and consultancy services in the areas of blinding, randomization, code breaks, labeling, packaging, storage and distribution of drugs, and retrieval and disposal of supplies. In addition, the company provides support services for new drug development and scale-up projects through its laboratory facilities. Further, it offers a range of services comprising feasibility assessments; cost estimates; study conduct; project planning and management; protocol and informed consent development; preparation, submission, and tracking of ethics applications; CTN/CTX preparation and submission; case report form design; investigator selection; site selection; healthy subject recruiting; patient recruiting; adverse event recording and reporting; data entry and quality control; processing and sample storage; and commercial sponsorship for the design, implementation, and management of clinical studies. The company is based in Boronia, Australia.
|Dr. Paul Donald Richard MacLeman BVSc, MBA, Grad Dip Tech Mgt, Grad Cert Eng,FAICD,
Chief Exec. Officer, Managing Director and Director
|Dr. Graeme L. Blackman OAM, BSc (Hons), Ph.D., FRACI, FTSE,
Founder, Director, Member of Nomination Committee and Member of Remuneration Committee
|Mr. Roman Najdecki B.Comm., CPA, ACIS,
Chief Financial Officer and Sec.
|Dr. David Sparling ,
VP of Legal & Corp. Devel.
| J. Kelly ,
VP of Clinical Services and Gen. Mang. of CMAX
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in AUD.|